The Long-Term Treatment of Schizophrenia With Antipsychotics: A Perennial Debate

World Psychiatry - United States
doi 10.1002/wps.20542
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Long-Term Treatment With Clozapine in Schizophrenia

British Journal of Psychiatry
MedicinePsychiatryMental Health
1996English

What Is the Role of Long-Acting Injectable Antipsychotics in the Treatment of Schizophrenia?

Journal of Clinical Psychiatry
MedicinePsychiatryMental Health
2014English

Treatment Discontinuation of Long-Acting Injectables or Oral Atypical Antipsychotics Among Medicaid Recipients With Schizophrenia

Journal of Medical Economics
Health Policy
2019English

Economic Evaluation of Antipsychotics for the Treatment of Schizophrenia: A Systematic Review

Jornal Brasileiro de Economia da Saúde
2017English

Antipsychotic Monotherapy and Polypharmacy in the Naturalistic Treatment of Schizophrenia With Atypical Antipsychotics

BMC Psychiatry
PsychiatryMental Health
2005English

What Is the Risk-Benefit Ratio of Long-Term Antipsychotic Treatment in People With Schizophrenia?

World Psychiatry
PsychiatryMental HealthPsychiatric Mental Health
2018English

Change in Level of Productivity in the Treatment of Schizophrenia With Olanzapine or Other Antipsychotics

BMC Psychiatry
PsychiatryMental Health
2011English

Cost/Effectiveness of Aripiprazole vs. Olanzapine in the Long-Term Treatment of Schizophrenia

Srpski Arhiv Za Celokupno Lekarstvo
Medicine
2019English

Designing a Long-Term Supportive Housing Facility for People With Schizophrenia

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy